NHS vs Private Access: NHS access is limited, mostly for type 2 diabetes or severe obesity with comorbidities
Originally developed for type 2 diabetes, these drugs have now proven to be some of the most powerful tools for sustainable weight loss
The MHRA recommends B12 monitoring in patients on long-term metformin treatment, and your GP can arrange appropriate blood tests and prescribe treatment if deficiency is confirmed
Lifestyle remains foundational : Diet, exercise, sleep, managing cardiovascular risks remain essential
Severe abdominal pain that radiates to the back, nausea, or vomiting should be evaluated right away
SUSTAIN-6 (semaglutide) [53], PIONEER 6 (semaglutide) [61], and LEADER (liraglutide) [54] looked at similar patient populations (over 50 years old with established cardiovascular disease) and found that GLP-1RAs produce a cardiovascular protective function relative to primary endpoints (Table 1)